A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer

BACKGROUND: Prostate cancer (PCa) is characterized by significant heterogeneity. Thus, novel prognostic indicators are required to improve prognosis and treatment. METHODS: Cysteine rich secretory protein 3 (CRISP3) and serine peptidase inhibitor Kazal type 1 (SPINK1) levels in expressed prostatic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lizhu, Zhang, Enchong, Guan, Johnny, Chen, Zhengjie, Ye, Jianfeng, Liu, Wangmin, He, Jieqian, Yin, Bo, Song, Yongsheng, Zhang, Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891445/
https://www.ncbi.nlm.nih.gov/pubmed/35252264
http://dx.doi.org/10.3389/fmed.2022.832415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891445/
https://www.ncbi.nlm.nih.gov/pubmed/35252264
http://dx.doi.org/10.3389/fmed.2022.832415

Ejemplares similares